01Jul
Novartis and Alcon FCPA Enforcement Action: Lessons Learned (Part III of III)
At the outset, Novartis is “lucky” – the settlement is relatively positive, despite its 2016 SEC enforcement action in China. Given Novartis weak culture of compliance (if anything, a better description may be a culture of non-compliance) and its status as a recidivist, Novartis could have been slammed with a stiffer enforcement action, including assignment of an independent corporate compliance monitor and a higher penalty. ...
By:
Michael Volkov
Related
We have all admired (or perhaps been one ourselves) the multitasking, be everywhere and do everythin...
Read More >
Supreme Court Confirms When an Employee is Entitled to Legal Representation - Precedential Decision...
Read More >
A gig economy business just prevailed in the first round of a misclassification legal battle worth k...
Read More >
-The DOJ has announced charges against four members of China’s military related to the 2017 cyberat...
Read More >
Company's Written Policy Terminated Women at the Fifth Month of Pregnancy Regardless of Ability to W...
Read More >
Does this situation sound familiar to you? You are a small business with a few employees. You know ...
Read More >